واکسن جدید کووید که شما استنشاق می کنید

چه چیزی را از این مقاله باید حذف کرد:

• The results of the study indicated that a heterologous booster with one dose of the Inhalation Convidecia™ for adults aged 18 years and above, who have received two doses of inactivated COVID-19 vaccine, can induce a higher level of neutralizing antibodies than those with a homogeneous booster of inactivated vaccine.
• today announced that Preprints with The Lancet, a collaboration between the research sharing platform SSRN and The Lancet, published a clinical study on the safety and immunogenicity of CanSinoBIO’s Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia™as a heterologous booster.
• eTurboNews مقالات فقط برای مشترکین است.